Featured Article

Where is RBQM Heading in The Future With AI?

Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM) in clinical trials. With experience at both CluePoints and Veeva, Young discusses AI’s role, transparency, and the future of risk management in clinical trials.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Download
Press Release
CluePoints Shortlisted for 2026 Scrip Awards Following 2023 and 2025 Wins
  • The two-time category winner secures finalist position in the Best Contract Research Organization (Specialist Providers) category....
Read More
Press Release
CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company
  • Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending...
Read More
Press Release
CluePoints Appoints Martin Magazzolo as Chief Commercial Officer
  • Wayne, PA – July 27, 2026 – CluePoints, provider of leading statistical and AI-driven software solutions,...
Read More